Vaishali Pharma Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: VAISHALI | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Vaishali Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Vaishali Pharma stock performance -

mw4me loader
P/E Ratio (SA):
25.72
Market Cap:
150.1 Cr.
52-wk low:
0
52-wk high:
0

Is Vaishali Pharma Ltd an attractive stock to invest in?

1. Is Vaishali Pharma Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vaishali Pharma Ltd is a average quality company.

2. Is Vaishali Pharma Ltd undervalued or overvalued?

The key valuation ratios of Vaishali Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Vaishali Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vaishali Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vaishali Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vaishali Pharma Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 12.6%10.1%8.8%11.3%8.2%5.4%3.2%6.7%12.5%15.4%-
Value Creation
Index
-0.1-0.3-0.4-0.2-0.4-0.6-0.8-0.5-0.10.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 12194.666.76467.875.160.153.875.869.780
Sales YoY Gr.--21.7%-29.5%-4.1%5.9%10.8%-20%-10.5%41%-8.1%-
Adj EPS 3.62-0.61.50.70.2-0.50.73.55.95.4
YoY Gr.--43.1%-129.2%NA-56.1%-69.2%-370%NA382.2%67.6%-
BVPS (₹) 38.440.440.18.319.520.320.321.32531.336
Adj Net
Profit
0.30.2-0.10.70.70.2-0.60.83.76.26
Cash Flow from Ops. -7-3.74.60.5-9.54.33.221.31.1-
Debt/CF from Ops. -2.7-6.84.649.6-1.945.28.715.812.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -5.9%0.6%5.1%-8.1%
Adj EPS 5.8%55.5%NA67.6%
BVPS-2.3%9.9%15.5%25.1%
Share Price - 26.4% 60.3% -5.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
9.75.1-1.519.85.61-2.73.515.218.616.2
Op. Profit
Mgn %
2.1-0.30.85.44.12.81.54.99.113.510.9
Net Profit
Mgn %
0.20.2-0.11.110.3-11.44.98.97.3
Debt to
Equity
6.17.86.65.80.90.80.80.80.80.4-
Working Cap
Days
149182244255283312396501390400195
Cash Conv.
Cycle
3263104107122115137152122168113

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.20%

Debt to equity has declined versus last 3 years average to 0.41

Sales growth is good in last 4 quarters at 17.36%

Sales growth has been subdued in last 3 years 5.05%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Vaishali Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 5.4 -
TTM Sales (₹ Cr.) 80.1 -
BVPS (₹.) 36 -
Reserves (₹ Cr.) 28 -
P/BV 3.89 -
PE 25.72 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 150
Equity (₹ Cr.) 10.7
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Vaishali Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vaishali Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales121956764687560547670
Operating Expenses 118956660657359516960
Manufacturing Costs0000000000
Material Costs114916256606951466455
Employee Cost 2222221111
Other Costs 2233327444
Operating Profit 2013321379
Operating Profit Margin (%) 2.0%-0.3%0.8%5.4%4.1%2.8%1.5%4.9%9.1%13.5%
Other Income 1431222222
Interest 3333333322
Depreciation 0000000001
Exceptional Items 0000000000
Profit Before Tax 1001110169
Tax 0000100022
Profit After Tax 0001110147
PAT Margin (%) 0.2%0.2%0.0%1.1%1.2%1.0%0.1%1.9%5.3%9.5%
Adjusted EPS (₹)0.60.3-0.10.30.80.70.01.03.86.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 3334212121222633
Share Capital 11137711111111
Reserves 3331141511121622
Minority Interest0000000000
Debt19242021181616162013
Long Term Debt3843354435
Short Term Debt1616151815111212177
Trade Payables31172515222524412818
Others Liabilities 11244657715
Total Liabilities 53464945646966868179

Fixed Assets

Gross Block1232223334
Accumulated Depreciation0110111222
Net Fixed Assets0211111112
CWIP 0000000001
Investments 0000000000
Inventories8331211113
Trade Receivables38344037454947675954
Cash Equivalents 1110000011
Others Assets5534161616161918
Total Assets 53464945646966868179

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -7-450-943211
PBT 1001110169
Adjustment 2012226321
Changes in Working Capital -10-44-3-122-2-3-5-7
Tax Paid 000000-10-1-2
Cash Flow From Investing Activity 02311000-10
Capex 0-2000000-10
Net Investments 0000000000
Others 0431100001
Cash Flow From Financing Activity 62-8-18-4-3-20-2
Net Proceeds from Shares 00001600000
Net Proceeds from Borrowing 05-42-22-11-22
Interest Paid -3-3-3-3-3-3-3-3-2-2
Dividend Paid 0000000000
Others 90-1-1-3-3005-2
Net Cash Flow -1000000010
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)10.285.12-0.9419.86.493.40.154.7816.522.26
ROCE (%)19.2314.0412.816.1812.759.86.8910.3318.8721.92
Asset Turnover Ratio2.371.911.41.361.251.130.890.710.910.87
PAT to CFO Conversion(x)-INF-INF-INF0-94INF20.250.14
Working Capital Days
Receivable Days115140205222221228293386301294
Inventory Days202218138765310
Payable Days10797123130115125172254198155

Vaishali Pharma Ltd Stock News

Vaishali Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vaishali Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Vaishali Pharma stood at ₹150.1.
The latest P/E ratio of Vaishali Pharma as of 01-Jan-1970 05:30 is 25.72.
The latest P/B ratio of Vaishali Pharma as of 01-Jan-1970 05:30 is 3.89.
The 52-week high of Vaishali Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vaishali Pharma is ₹80.12 ( Cr.) .

About Vaishali Pharma Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.